Triazolo[4,5-d]pyrimidines as Validated General Control Nonderepressible 2 (GCN2) Protein Kinase Inhibitors Reduce Growth of Leukemia Cells

Triazolo[4,5-d]pyrimidines as Validated General Control Nonderepressible 2 (GCN2) Protein Kinase Inhibitors Reduce Growth of Leukemia Cells

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Computational and Structural Biotechnology Journal - Volume 16, 2018, Pages 350-360

Lea Lough, Dan Sherman, Manuel Beccera-Flores, Olga Lavinda, Eric Ni, Hong Wang, Raoul Tibes, Timothy Cardozo,